Stock Alert: Amneal (AMRX) Trades 8.09% Lower August 5

Equities Staff  |

Amneal Pharmaceuticals Inc - Class A (NYSE:AMRX) shares changed 8.09% today on 1,791,971 shares - compared to the 30 day average of 597,813 shares traded.

With today’s closing at $3.18 the company has a 50 day moving average of $3.31.

The company expects its next earnings on 2022-08-05.

Amneal lost 27.77% so far this year.

For technical charts, analysis, and more on Amneal visit the company profile.

About Amneal Pharmaceuticals Inc - Class A

Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

To get more information on Amneal Pharmaceuticals Inc - Class A and to follow the company's latest updates, you can visit the company's profile page here: Amneal Pharmaceuticals Inc - Class A's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan

Market Movers

Sponsored Financial Content